Mario Gattuso

Mario Gattuso leads pharmaceutical business development at Quantinuum, working with industry partners to identify and advance practical applications of quantum computing in drug discovery and development.

He brings extensive experience in scientific software, computational chemistry, and commercial strategy, including previous roles at OpenEye Scientific (now Cadence Molecular Sciences). Throughout his career, he has worked closely with pharmaceutical and biotechnology organizations to support the adoption of advanced computational technologies in drug discovery.

At Quantinuum, Mario focuses on connecting emerging quantum capabilities with pharmaceutical research challenges, developing industry collaborations, and helping organizations evaluate where quantum computing can complement existing computational approaches.